Patent ID: 9345767
Filing Date: 2016-05-24
CPC Classification: A61K,A61P,C07K,C12Q,G01N

Claim Text:
1. A method for treating gastric cancer in a patient in need of such treatment, comprising: (1) measuring an expression level of EGFR contained in a biological sample obtained from the patient with an immunohistochemical staining method (IHC method); (2) comparing the expression level of EGFR obtained in step (1) with a corresponding predetermined cut-off point, wherein the corresponding predetermined cut-off point of the expression level of EGFR protein is 1+; and (3) thereafter performing chemotherapy by administering a combination drug containing tegafur, gimeracil, and oteracil potassium in combination with an EGFR inhibitor to said patient when the comparison in step (2) reveals that the expression level of EGFR is greater than the cut-off point.